B

Biogen

Develops therapies for neurological disorders

Global Launch Excellence Lead - SMA

Program ManagementConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • A bachelor's degree in business, life sciences, or a related discipline is required.
  • At least 10 years of experience in the pharmaceutical or biotechnology industry, including at least 3 years in launch-readiness roles, is required.
  • Strong commercial experience, ideally at regional or global levels, is required.
  • Demonstrated proficiency in AI-enabled tools, advanced analytics, and digital innovations is required.
  • Experience in rare diseases or neuromuscular conditions is required.
  • Ability to lead in a matrix organization is required.
  • International travel of up to 15% is anticipated.

Responsibilities

  • Lead and collaborate with cross-functional teams to develop impactful launch plans for the SMA portfolio.
  • Manage integrated launch plans, including timelines, budgets, and risks, with strategic and operational rigor.
  • Integrate the IDU and Thecaflex programs, facilitate decision-making, and remove barriers for launch priorities.
  • Build and maintain tools to plan and track launch progress and enhance team collaboration.
  • Coordinate the development of presentations for strategic planning and decision-making.
  • Define and execute a global engagement strategy across healthcare providers, patients, and caregivers.
  • Provide regular launch progress updates to leadership and key governance committees.
  • Enhance organizational capabilities through new methods and tools to maximize launch excellence.

Desired Qualifications

  • An advanced degree (MBA, MSc, PhD, or PharmD) is preferred.
  • Experience in global marketing or brand leadership is preferred.
  • Exposure to pre-launch, launch, and early in-line phases is preferred.
  • A strong track record of delivering results while enhancing collaborative culture and employee engagement is preferred.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs